SPECIAL NOTICE
A -- TECHNOLOGY/BUSINESS OPPORTUNITY BIOBRIEFCASE ? A PORTABLE INSTRUMENT FOR AUTONOMOUS DETECTION OF BIOAGENTS
- Notice Date
- 3/23/2006
- Notice Type
- Special Notice
- NAICS
- 238990
— All Other Specialty Trade Contractors
- Contracting Office
- Department of Energy, Lawrence Livermore National Laboratory (DOE Contractor), Industrial Partnerships & Commercialization, 7000 East Avenue L-795, Livermore, CA, 94550
- ZIP Code
- 94550
- Solicitation Number
- Reference-Number-FBO126-06
- Response Due
- 4/24/2006
- Archive Date
- 4/25/2006
- Description
- TECHNOLOGY/BUSINESS OPPORTUNITY BIOBRIEFCASE ? A PORTABLE INSTRUMENT FOR AUTONOMOUS DETECTION OF BIOAGENTS Opportunity: Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy (DOE), is offering the opportunity to commercialize LLNL's portable autonomous bioagent detection system ? BioBriefcase. Background: There is a critical need for distributed biothreat agent sensor networks that can operate in civilian applications. These platforms need to have several key properties: 1) they need to be capable of detecting pathogens within a 1 to 2 hours, allowing for enough time to respond to an event; 2) they need to be extremely low cost to maintain, since continuous monitoring is essential for many applications; and 3) they need to have sufficient sensitivity to cover a broad geographical area and have sufficient selectivity to virtually eliminate false positives. Currently available bio-weapons detection systems are designed primarily for military use. These military systems are expensive to deploy and ultimately unsuited for civilian protection. Description: LLNL?s BioBriefcase is a compact and portable instrument capable of autonomously detecting the full spectrum of bioagents, including bacteria, viruses and toxins in the air. It uses the state of art technologies to collect, process, and analyze samples to detect, and identify genetic and protein signatures of bioagents. Advantages: The compacted size does not compromise the performance. The BioBriefcase features rapid response, multiplex capability, small reagent consumption, relatively low cost, with high sensitivity and short response time. Potential Applications: It is an ideal instrument for monitoring bioagents in the environment, such as in open space, inside a building or in a transit system when quick and accurate detection is required. It is also a useful tool for defense, first responders, homeland security applications, agriculture, or environmental monitoring in factories or buildings. A simple redesign may convert it to a bench top instrument for medical diagnosis and scientific research with autonomous sampling and processing of biological samples for simultaneously measuring or identifying specific DNA/RNA or protein signatures. Development Status: LLNL has filed multiple patent applications to protect the BioBriefcase technologies. The patent applications cover several unique inventions in sample collection, concentration, processing and amplification, and data analysis. LLNL is seeking one or more industry partners to commercialize BioBriefcase through licensing LLNL?s BioBriefcase intellectual property portfolio and funding cooperative research to further develop the instrument. Moving critical technology beyond the Laboratory to the commercial world helps our licensees gain a competitive edge in the marketplace. All licensing activities are conducted under policies relating to the strict nondisclosure of company proprietary information. Please visit the IPAC website at http://www.llnl.gov/IPandC/workwithus/partneringprocess.php for more information on working with LLNL and the industrial partnering and technology transfer process. Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's BioBriefcase technology should provide a written statement of interest, which includes the following: 1. Company Name and address. 2. The name, address, and telephone number of a point of contact. 3. A description of corporate expertise and facilities relevant to commercializing this technology. Written responses should be directed to: Lawrence Livermore National Laboratory Industrial Partnerships and Commercialization P.O. Box 808, L-795 Livermore, CA 94551-0808 Attention: FBO 126-06 Please provide your written statement within thirty (30) days from the date this announcement is published to ensure consideration of your interest in LLNL's BioBriefcase technology.
- Record
- SN01013220-W 20060325/060323211836 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |